Thomas Kaley

Chief, Neuro-Oncology and Cancer Neurology Service · New York Presbyterian Hospital

Credentials: · · ·

History

Neuro-Oncology and Cancer Neurology Service Division · New York Presbyterian Hospital
Present
Department of Neurology · New York Presbyterian Hospital
Present
Institutional Review Board Department · New York Presbyterian Hospital
Present

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2025–2028
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2017–2027
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2016–2027
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2013–2027